Search by Drug Name or NDC

NDC 00002-4116-30 Zyprexa 7.5 mg/1 Details

Zyprexa 7.5 mg/1

Zyprexa is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eli Lilly and Company. The primary component is OLANZAPINE.

MedlinePlus Drug Summary

Olanzapine is used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions) in adults and teenagers 13 years of age and older. It is also used to treat bipolar disorder (manic depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods) in adults and teenagers 13 years of age and older. Olanzapine is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.

Related Packages: 00002-4116-30
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Olanzapine

Product Information

NDC	00002-4116
Product ID	0002-4116_c5ba5946-0f0a-445b-b370-6b98a6dbf6a3
Associated GPIs	59157060000315
GCN Sequence Number	027959
GCN Sequence Number Description	olanzapine TABLET 7.5 MG ORAL
HIC3	H7T
HIC3 Description	ANTIPSYCHOTIC,ATYPICAL,DOPAMINE,SEROTONIN ANTAGNST
GCN	15081
HICL Sequence Number	011814
HICL Sequence Number Description	OLANZAPINE
Brand/Generic	Brand
Proprietary Name	Zyprexa
Proprietary Name Suffix	n/a
Non-Proprietary Name	Olanzapine
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	7.5
Active Ingredient Units	mg/1
Substance Name	OLANZAPINE
Labeler Name	Eli Lilly and Company
Pharmaceutical Class	Atypical Antipsychotic [EPC]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA020592
Listing Certified Through	2024-12-31

Package

NDC 00002-4116-30 (00002411630)

Pricing Information	N/A
NDC Package Code	0002-4116-30
Billing NDC	00002411630
Package	30 TABLET in 1 BOTTLE (0002-4116-30)
Marketing Start Date	1996-10-01
NDC Exclude Flag	N